Deep generative molecular design and its value in modern drug discovery

Generative AI's greatest promise lies not in generating more molecules, but in generating better hypotheses, structures that are synthetically accessible, biologically plausible, optimized across potency, selectivity, and pharmacokinetics. The next phase will be led by multimodal foundation models capable of reasoning jointly about chemistry, protein structure, and cellular response, supported by automated synthesis and high-throughput experimentation. As these components are integrated, generative molecular design will guide lead optimization and reshape how new therapies are discovered and developed.